Banco Bilbao Vizcaya Argentaria S.A. Invests $492,000 in HealthEquity, Inc. $HQY

Banco Bilbao Vizcaya Argentaria S.A. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 4,666 shares of the company’s stock, valued at approximately $492,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC boosted its stake in shares of HealthEquity by 2.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock worth $397,000 after buying an additional 108 shares during the last quarter. Ieq Capital LLC raised its holdings in HealthEquity by 4.4% during the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock worth $260,000 after acquiring an additional 123 shares in the last quarter. Sheets Smith Wealth Management boosted its position in HealthEquity by 1.9% during the second quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock valued at $882,000 after purchasing an additional 157 shares during the last quarter. Nordea Investment Management AB boosted its position in HealthEquity by 0.3% during the second quarter. Nordea Investment Management AB now owns 59,732 shares of the company’s stock valued at $6,319,000 after purchasing an additional 164 shares during the last quarter. Finally, AlphaQ Advisors LLC grew its stake in HealthEquity by 5.1% in the first quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company’s stock valued at $303,000 after purchasing an additional 165 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

HealthEquity stock opened at $102.74 on Wednesday. The company has a market capitalization of $8.85 billion, a price-to-earnings ratio of 62.27, a PEG ratio of 1.36 and a beta of 0.47. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The stock’s 50 day moving average is $94.36 and its 200-day moving average is $96.24.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The business had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on HQY shares. Jefferies Financial Group upped their price objective on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada boosted their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. Barrington Research reaffirmed an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research report on Friday, August 29th. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, BMO Capital Markets assumed coverage on shares of HealthEquity in a research report on Thursday, November 13th. They issued a “market perform” rating and a $100.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $119.00.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 9,281 shares of company stock worth $859,867 over the last 90 days. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.